NASDAQ:VRML - Vermillion Stock Price, Forecast & News

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

Vermillion, Inc. (NASDAQ:VRML) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.06) EPS for the quarter. The company earned $1.14 million during the quarter. Vermillion had a negative return on equity of 163.08% and a negative net margin of 353.32%. View Vermillion's Earnings History.

Vermillion is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for Vermillion.

News stories about VRML stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vermillion earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Vermillion.

Vermillion saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,420,000 shares, an increase of 24.8% from the December 31st total of 2,740,000 shares. Based on an average daily volume of 218,800 shares, the days-to-cover ratio is presently 15.6 days. Approximately 6.7% of the shares of the company are short sold. View Vermillion's Current Options Chain.

Some companies that are related to Vermillion include Oxford Immunotec Global (OXFD), Meridian Bioscience (VIVO), Nymox Pharmaceutical (NYMX), Celldex Therapeutics (CLDX), ImmuCell (ICCC), Riot Blockchain (RIOT), Trinity Biotech (TRIB), GeneNews (GNWSF), Arca Biopharma (ABIO), Achieve Life Sciences (ACHV), Akers Biosciences (AKER), BG Medicine (BGMD), Fluoropharma Medical (FPMI) and Response Genetics (RGDXQ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Vermillion investors own include CombiMatrix (CBMX), Accelerate Diagnostics (AXDX), TrovaGene (TROV), Himax Technologies (HIMX), Opko Health (OPK), NovaBay Pharmaceuticals (NBY), Charter Communications (CHTR), Fluidigm (FLDM), Idera Pharmaceuticals (IDRA) and Genworth Financial (GNW).

Vermillion's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include B. Riley Wealth Management Inc. (0.46%), Alyeska Investment Group L.P. (0.29%), Geode Capital Management LLC (0.25%), Cannell Peter B & Co. Inc. (0.12%), Magnus Financial Group LLC (0.09%) and Trellus Management Company LLC (0.05%). Company insiders that own Vermillion stock include David Schreiber, Jack W Schuler, James T Lafrance, Robert Harry Beechey and Valerie Barber Palmieri. View Institutional Ownership Trends for Vermillion.

VRML stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P. and Cannell Peter B & Co. Inc.. View Insider Buying and Selling for Vermillion.

VRML stock was acquired by a variety of institutional investors in the last quarter, including B. Riley Wealth Management Inc., Trellus Management Company LLC, Geode Capital Management LLC and Magnus Financial Group LLC. Company insiders that have bought Vermillion stock in the last two years include Jack W Schuler, Robert Harry Beechey and Valerie Barber Palmieri. View Insider Buying and Selling for Vermillion.

Shares of VRML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VRML stock can currently be purchased for approximately $0.89.

Vermillion has a market capitalization of $86.54 million and generates $3.05 million in revenue each year. Vermillion employs 43 workers across the globe.View Additional Information About Vermillion.

The official website for Vermillion is http://www.vermillion.com/.

Vermillion's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]